Scientists from Monash University are partnering with colleagues at the Yale School of Medicine in New Haven, Conn., to ...

Among U.S. adults with obstructive sleep apnea, there has been an increase in deaths related to ischemic heart disease from 1999 to 2022, according to results published in Respiratory Medicine.“These ...

Ultimately, investigators found a significant reduction in ischemic stroke risk with asundexian compared to placebo, both in combination with antiplatelet therapy. Additionally, participants had no ...

Two NEJM trials report conflicting results on long-term beta-blockers after MI in patients with preserved ejection fraction, ...

Topline data show the Factor XIa inhibitor asundexian lowers recurrent stroke risk vs placebo with no increase in major bleeding events.

Quality improvement programs markedly increase sleep apnea testing in stroke patients, showing effective ways to improve guideline-based care.

Scientists found that having both gum disease and cavities was associated with a sharply higher risk of stroke and heart problems. Regular dental care may be an easy, overlooked way to protect not ...

Tenecteplase shows no benefit over standard care for 90-day functional recovery in patients with minor ischemic stroke and disabling deficits.

Scientists from Monash University are partnering with colleagues at the Yale School of Medicine in New Haven, Conn., to develop a new, high-tech approach for treating ischemic stroke by enhancing ...

Ischemic colitis reduces blood flow to the colon or large intestine. Mesenteric ischemia is a reduction in blood flow to the small intestine due to the narrowing of the arteries. Both conditions are ...

Canadian Patent No. 3043594, entitled “Method of Using Human Mesenchymal Stem Cells to Effect Cellular and Humoral Immunity,” provides Longeveron with patent rights in Canada through 2037.